INVA

Innoviva, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$22.99

Market Cap

$1.48B

Beta

0.40

P/E

7.7

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+14.52%

EPS Growth (YoY)+500.00%

Revenue CAGR 3Y+7.77%

P/E Ratio7.7

PEG Ratio0.02

FCF Yield+13.16%

Debt / Equity0.23

Interest Coverage-1.0x

No credit card required

Already have an account? Sign in to view the full analysis for INVA.